Literature DB >> 25299315

Selected case from the Arkadi M. Rywlin International Pathology Slide Series: Mitochondrial myopathy presenting with chronic progressive external ophthalmoplegia (CPEO): a case report.

Michele Bisceglia1, Paola Crociani, Danilo Fogli, Antonio Centola, Carlos A Galliani, Gianandrea Pasquinelli.   

Abstract

A 43-year-old female patient diagnosed with chronic progressive external ophthalmoplegia (CPEO) because of mitochondrial myopathy documented by muscle biopsy is presented. The chief complaints were represented by blepharoptosis and ophthalmoplegia. The muscle biopsy was evaluated by histology, using the appropriate histochemical and histoenzimological stains. Ragged red fibers with Gomori trichrome stain were seen, which showed cytochrome c oxydase deficiency and abnormal succinate dehydrogenase staining in around 20% of muscle fibres. Electron microscopy was also performed which demonstrated abnormal, hyperplastic, pleomorphic, and hypertrophic mitochondria, characterized by paracrystalline inclusions arranged in parallel rows ("parking-lot" inclusions), consisting of rectangular arrays of mitochondrial membranes in a linear or grid-like pattern. In conclusion, mitochondrial myopathy was definitely diagnosed. Although molecular analysis, which was subsequently carried out, failed to reveal mutations in the mitochondrial DNA or in selected nuclear genes, the pathologic diagnosis was not changed. The differential diagnosis of CPEO with other forms of ocular myopathies as well as the possible association of CPEO with systemic syndromes is discussed. Ophtalmologists and medical internists should always suspect CPEO when dealing with patients affected by ocular myopathy, either in its pure form or in association with other myopathic or systemic signs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25299315     DOI: 10.1097/PAP.0000000000000045

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  2 in total

1.  Unilateral Ptosis and Homolateral Hemifacial Weakness in Chronic Progressive External Ophthalmoplegia.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroophthalmology       Date:  2017-03-24

2.  Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes.

Authors:  Silvia Vidali; Raffaele Gerlini; Kyle Thompson; Jill E Urquhart; Jana Meisterknecht; Juan Antonio Aguilar-Pimentel; Oana V Amarie; Lore Becker; Catherine Breen; Julia Calzada-Wack; Nirav F Chhabra; Yi-Li Cho; Patricia da Silva-Buttkus; René G Feichtinger; Kristine Gampe; Lillian Garrett; Kai P Hoefig; Sabine M Hölter; Elisabeth Jameson; Tanja Klein-Rodewald; Stefanie Leuchtenberger; Susan Marschall; Philipp Mayer-Kuckuk; Gregor Miller; Manuela A Oestereicher; Kristina Pfannes; Birgit Rathkolb; Jan Rozman; Charlotte Sanders; Nadine Spielmann; Claudia Stoeger; Marten Szibor; Irina Treise; John H Walter; Wolfgang Wurst; Johannes A Mayr; Helmut Fuchs; Ulrich Gärtner; Ilka Wittig; Robert W Taylor; William G Newman; Holger Prokisch; Valerie Gailus-Durner; Martin Hrabě de Angelis
Journal:  EMBO Mol Med       Date:  2021-11-08       Impact factor: 14.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.